NH SPAC 2 (KQ:206640) — Market Cap & Net Worth
Market Cap & Net Worth: NH SPAC 2 (206640)
NH SPAC 2 (KQ:206640) has a market capitalization of $136.73 Million (₩201.76 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18099 globally and #789 in its home market, demonstrating a -2.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NH SPAC 2's stock price ₩9410.00 by its total outstanding shares 21441206 (21.44 Million). Also see balance sheet size of NH SPAC 2 for a full breakdown of the balance sheet.
NH SPAC 2 Market Cap History: 2015 to 2026
NH SPAC 2's market capitalization history from 2015 to 2026. Data shows change from $457.14 Million to $136.73 Million (-8.55% CAGR). Also see 206640 operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
NH SPAC 2 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$234.31 Billion | 0.06% | #295 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$234.31 Billion | 0.06% | #295 of 1384 |
Weight: NH SPAC 2's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NH SPAC 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NH SPAC 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NH SPAC 2 share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
NH SPAC 2's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
NH SPAC 2's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $256.07 Million | $54.97 Billion | $12.62 Billion | 0.00x | 0.02x |
| 2017 | $244.85 Million | $52.59 Billion | -$2.15 Billion | 0.00x | N/A |
| 2018 | $147.05 Million | $66.20 Billion | -$1.69 Billion | 0.00x | N/A |
| 2019 | $133.31 Million | $72.80 Billion | $11.65 Billion | 0.00x | 0.01x |
| 2020 | $330.39 Million | $144.13 Billion | $45.49 Billion | 0.00x | 0.01x |
| 2021 | $237.15 Million | $157.71 Billion | $44.37 Billion | 0.00x | 0.01x |
| 2022 | $146.83 Million | $118.08 Billion | $24.15 Billion | 0.00x | 0.01x |
| 2023 | $293.65 Million | $134.22 Billion | $25.95 Billion | 0.00x | 0.01x |
| 2024 | $243.82 Million | $138.16 Billion | $27.26 Billion | 0.00x | 0.01x |
| 2025 | $190.64 Million | $162.09 Billion | $23.65 Billion | 0.00x | 0.01x |
Competitor Companies of 206640 by Market Capitalization
Companies near NH SPAC 2 in the global market cap rankings as of September 18, 2026. Review how tangible is NH SPAC 2's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to NH SPAC 2 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
NH SPAC 2 Historical Marketcap From 2015 to 2026
Between 2015 and today, NH SPAC 2's market cap moved from $457.14 Million to $ 136.73 Million, with a yearly change of -8.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩136.73 Million | -28.28% |
| 2025 | ₩190.64 Million | -21.81% |
| 2024 | ₩243.82 Million | -16.97% |
| 2023 | ₩293.65 Million | +100.00% |
| 2022 | ₩146.83 Million | -38.09% |
| 2021 | ₩237.15 Million | -28.22% |
| 2020 | ₩330.39 Million | +147.84% |
| 2019 | ₩133.31 Million | -9.34% |
| 2018 | ₩147.05 Million | -39.94% |
| 2017 | ₩244.85 Million | -4.38% |
| 2016 | ₩256.07 Million | -43.98% |
| 2015 | ₩457.14 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of NH SPAC 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $136.73 Million USD |
| MoneyControl | $136.73 Million USD |
| MarketWatch | $136.73 Million USD |
| marketcap.company | $136.73 Million USD |
| Reuters | $136.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NH SPAC 2
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testi… Read more